REVCORE Competitors

Dräger is an international leader in the fields of medical and safety technology. The family-run company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group. The Company's long-term success is based on the four key strengths of its value-driven corporate culture: customer intimacy, professional employees, continuous innovation and a commitment to outstanding quality. “Technology for Life” is the Company's guiding philosophy. Whether in the operating room, the intensive care ward, the fire department or rescue services: Dräger products protect, support, and save lives. The Company has 16,598 employees worldwide and is currently represented in over 190 countries. Dräger has sales and service subsidiaries in about 50 countries. The relevant development and production sites are located in Germany, Chile, China, the Czech Republic, France, India, Lithuania, Norway, Serbia, South Africa, Sweden, Switzerland, United Kingdom, and the United States of America http://t4.life/dataprotection Drägerwerk AG & Co. KGaA Board of Managing Directors: Stefan Dräger (Chairman), Stefanie Hirsch, Rainer Klug, Gert-Hartwig Lescow, Dr. Reiner Piske, Anton Schrofner Company registered at Lübeck Local Court Register of Companies Number: HRB 7903 HL Turnover tax identification number as per § 27a Turnover Tax Law: DE 135082211 General partner: Drägerwerk Verwaltungs AG Company registered at Lübeck Local Court Register of Companies Number: HRB 7395 HL

With a 170-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have approximately 9 100 employees at 69 established offices in over 50 countries and we improve the health of patients in more than 150 countries through our high quality, affordable medicines. Aspen focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through our key business segments. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands. Our manufacturing capabilities cover a wide variety of product types including steriles, oral solid dose, liquids, semi-solids, biologicals and active pharmaceutical ingredients. We operate 23 manufacturing facilities across 15 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines.

The Netcare Group (JSE: NTC) offers a unique, comprehensive range of medical services across the healthcare spectrum, enabling us to serve the health and care needs of each individual who entrust their care to us. Our focus on implementing sophisticated digital systems will enable us to provide care that is fully integrated and an enhanced experience across our Group's operations. At Netcare, we are striving to change healthcare for the better. In addition to its world-class acute private hospital services, Netcare provides: o radiosurgery, radiotherapy, chemotherapy, bone marrow transplant and robotic-assisted surgery through Netcare Cancer Care; o primary healthcare services through Medicross; o emergency medical services through Netcare 911; o occupational health and employee wellness services through Netcare Occupational Health; o mental health and psychiatric services through Akeso; o innovative solutions to increase access to quality and affordable private healthcare through NetcarePlus; and o renal dialysis services through National Renal Care (NRC). Netcare is also a leading private trainer of emergency medical and nursing personnel in the country. For more information visit www.netcare.co.za.